Skip to main content
Premium Trial:

Request an Annual Quote

National Institute on Drug Abuse Awards Gene Logic $6 Million Contract For Preclinical Studies of Medications to Treat Drug Addiction

NEW YORK, Oct. 8 (GenomeWeb News) - Gene Logic announced today that it will receive up to $6 million over the next four years from the National Institute on Drug Abuse to provide preclinical safety and pharmacology studies focused on developing safe and effective medications for the treatment of drug addiction.

 

Under terms of the agreement, Gene Logic will perform studies and services requested by NIDA. The studies will focus on developing safety data for selected compounds that have already been demonstrated to be efficacious in animal models.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.